New weight loss drug to be sold on Trump's pharmaceutical cost comparison platform
CBS News • • business
Key Points:
- Foundayo, a first-of-its-kind GLP-1 weight loss pill that does not require an empty stomach, will be offered on President Trump's drug price comparison platform, TrumpRx, providing greater access for needle-averse patients.
- TrumpRx will offer Foundayo starting at $149 for the first dose to uninsured Americans, with refills priced at $199 and future prescriptions at $299, matching prices on Eli Lilly’s direct-to-consumer platform, Lilly Direct.
- The platform aims to serve as a comprehensive "one stop shop" for consumers to compare all GLP-1 drugs, with Medicare patients paying around $50 and privately insured patients about $25 for the medication.
- Foundayo is the first drug approved under the FDA’s priority voucher program, which expedited its review to just 50 days, and Eli Lilly plans to begin shipping the pill on April 6.
- The White House indicated that Foundayo could be featured on TrumpRx as soon as Thursday, expanding affordable options for weight loss medication.
